Linear regression analysis | Logistic regression analysis | ||||||||
---|---|---|---|---|---|---|---|---|---|
PHQ-9 scores | PHQ-9 score ≥5 | PHQ-9 score ≥10 | |||||||
Parameter estimate | 95% CI | p Value | OR | 95% CI | p Value | OR | 95% CI | p Value | |
Log urinary ACR (per 1 SD) | 0.39 | 0.13 to 0.65 | 0.003 | 1.20 | 1.06 to 1.37 | 0.005 | 1.22 | 1.03 to 1.46 | 0.024 |
eGFR (per 1 SD) | 0.02 | –0.27 to −0.30 | 0.909 | 0.97 | 0.84 to 1.12 | 0.648 | 1.02 | 0.84 to 1.23 | 0.856 |
Age (per 10 years) | −0.57 | −0.76 to −0.38 | <0.001 | 0.75 | 0.68 to 0.83 | <0.001 | 0.80 | 0.70 to 0.92 | 0.001 |
Gender (men vs women) | −0.58 | −1.00 to −0.17 | 0.006 | 0.68 | 0.55 to 0.83 | <0.001 | 0.71 | 0.52 to 0.95 | 0.022 |
HbA1c (per 1.0%) | 0.35 | 0.18 to 0.53 | <0.001 | 1.15 | 1.05 to 1.25 | 0.002 | 1.24 | 1.12 to 1.39 | <0.001 |
Type of diabetes (type 2 vs 1) | 0.09 | −0.60 to 0.77 | 0.803 | 1.06 | 0.75 to 1.49 | 0.754 | 0.94 | 0.57 to 1.53 | 0.791 |
Oral hypoglycemic agents (yes vs no) | 0.39 | −0.11 to 0.90 | 0.127 | 1.46 | 1.12 to 1.89 | 0.005 | 1.19 | 0.82 to 1.72 | 0.361 |
Injections (yes vs no) | 0.15 | −0.35 to 0.64 | 0.560 | 1.16 | 0.91 to 1.49 | 0.235 | 0.90 | 0.64 to 1.28 | 0.574 |
Antihypertensive agents (yes vs no) | −0.23 | −0.69 to 0.22 | 0.318 | 1.03 | 0.82 to 1.30 | 0.802 | 0.83 | 0.59 to 1.16 | 0.279 |
Antilipemic agents (yes vs no) | 0.69 | 0.25 to 1.12 | 0.002 | 1.12 | 0.90 to 1.39 | 0.331 | 1.43 | 1.04 to 1.95 | 0.026 |
Retinopathy (yes vs no) | 0.81 | 0.36 to 1.25 | <0.001 | 1.23 | 0.98 to 1.53 | 0.069 | 1.55 | 1.13 to –2.11 | 0.006 |
Neuropathy (yes vs no) | 1.66 | 1.24 to 2.09 | <0.001 | 2.26 | 1.80 to 2.83 | <0.001 | 2.44 | 1.72 to 3.74 | <0.001 |
Cardiac disease (yes vs no) | 0.61 | −0.01 to 1.23 | 0.055 | 1.43 | 1.05 to 1.95 | 0.023 | 1.26 | 0.81 to 1.95 | 0.301 |
Stroke (yes vs no) | 2.16 | 0.73 to 3.58 | 0.003 | 2.58 | 1.29 to 5.16 | 0.007 | 2.33 | 1.03 to 5.28 | 0.043 |
Gangrene (yes vs no) | 1.29 | −0.88 to 3.47 | 0.244 | 1.14 | 0.41 to 3.21 | 0.801 | 1.41 | 0.43 to 4.68 | 0.573 |
ACR, albumin-to-creatinine ratio; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; PHQ-9, Patient Health Questionnaire-9.